Key result
Home-based cardiac rehabilitation modestly improves VO2peak by ~0.7 mL/kg/min vs center-based rehabilitation.
Why the study?
Center-based cardiac rehabilitation faces access and adherence barriers, while the extent to which specific home-based cardiac rehabilitation delivery models translate into clinical and patient-centered benefits remains unclear.
Does home-based cardiac rehabilitation improve functional capacity and adherence compared to center-based cardiac rehabilitation in adult patients with cardiovascular disease?
Systematic Review (n=1,249)
Does home-based cardiac rehabilitation improve functional capacity and adherence compared to center-based cardiac rehabilitation in adult patients with cardiovascular disease?
Effect estimate: MD 0.68 mL·kg−1·min−1 (VO2peak) favoring HBCR (95% CI 95% CI 0.06 to 1.29)
Home-based cardiac rehabilitation yields functional capacity and adherence outcomes comparable to or slightly better than center-based programs, supporting its use as a scalable alternative to expand access to secondary prevention.
Aim: Center-based cardiac rehabilitation (CBCR) is a cornerstone of secondary prevention, yet participation remains limited due to access constraints and adherence barriers. Home-based cardiac rehabilitation (HBCR) has evolved from conventional telephone- and logbook-supported programs to technology-assisted telerehabilitation. However, the extent to which specific delivery models translate into clinical and patient-centered benefits remains unclear. Purpose: To compare HBCR and CBCR delivery models and outcomes, and to evaluate whether variation in HBCR delivery approaches is associated with differences in functional capacity, adherence, quality of life, and cardiovascular risk factors. Patients and Methods: A PRISMA 2020-guided systematic review of randomized controlled trials compared HBCR with Phase II/III CBCR. Risk of bias was assessed using RoB 2. Outcomes were synthesized narratively, and random-effects meta-analyses (inverse-variance) were conducted where data were sufficiently comparable for VO 2 peak, 6-minute walk distance (6MWD), and adherence. Results: Fourteen trials (2002– 2023), including 1,085 participants (22– 242 per study), were included. HBCR delivery clustered into traditional programs (exercise prescription with telephone/logbook follow-up) and technology-assisted models (web/app platforms, wearable monitoring, and/or video-supported supervision). Overall risk of bias was low in six trials, some concerns in seven, and high in one; concerns were most commonly related to randomization, while outcome measurement was consistently low risk. Meta-analysis favored HBCR for VO 2 peak at follow-up (MD 0.68 mL·kg − 1 ·min − 1 , 95% CI 0.06– 1.29; I 2 =4%), whereas 6MWD showed no between-setting difference (MD − 6.77 m, 95% CI − 55.06 to 41.52; I 2 =61%). Adherence modestly favored HBCR (MD 3.24 sessions, 95% CI − 0.10 to 6.58; I 2 =70%). HRQoL and cardiovascular risk factors were generally comparable. Conclusion: HBCR yields outcomes comparable to CBCR, with small advantages in VO 2 peak and adherence, supporting the scalability of HBCR, particularly technology-assisted models, to expand rehabilitation access and uptake.
No takes yet. Share an insight, caveat, or question.
Karisa et al. (2026) conducted a systematic review in Adult patients (≥18 years) with cardiovascular disease including stable coronary artery disease post-myocardial infarction, post-CABG surgery, percutaneous revascularization, and selected heart failure populations (HFrEF/HFpEF) (n=1,249). Home-based cardiac rehabilitation (HBCR) vs. Phase II/III center-based cardiac rehabilitation (CBCR) with matched exercise dose was evaluated on Functional capacity measured by VO2peak and 6-minute walk distance (6MWD) (MD 0.68 mL·kg−1·min−1 (VO2peak) favoring HBCR, 95% CI 95% CI 0.06 to 1.29). Home-based cardiac rehabilitation modestly improved VO2peak by 0.68 mL·kg−1·min−1 compared to center-based rehabilitation in adults with cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: